Patent №
US 7,087,751
Granted
2006-08-08
Filed 2002
Owner
SCHERING CORPORATION
Lab
—
AI components
1
evo
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
10050488
This invention relates to a novel process for the synthesis of Temozolomide, an antitumor compound, and analogs, and to intermediates useful in this novel process.
AI classification
Evolutionary computation0.55
Machine learning0.00
Natural language0.00
AI hardware0.00
Planning0.00
Vision0.00
Speech0.00
Knowledge representation0.00
Ownership
SCHERING CORPORATION
assignment · 126550241
Assignors
KUO, SHEN-CHUN, MAS, JANET L., HOU, DONALD
On an employer assignment, the assignors are typically the inventors.
From the same owner
SYSTEM AND METHOD FOR SEGMENTING M-MODE ULTRASOUND IMAGES SHOWING BLOOD VESSEL WALL MOTION OVER TIMEUS 8,861,811 · 2014TREATMENT OF DIABETES USING ANTIBODIES TO IL-23, IL-23 RECEPTOR AND IL-17US 7,820,168 · 2010X-RAY ARRANGEMENT AND X-RAY CONTRAST PROCESS FOR IMAGING AN OBJECT UNDER EXAMINATION THAT CONTAINS AT LEAST ONE RADIOPAQUE ELEMENT AS WELL AS USE OF THE X-RAY ARRANGEMENTUS 7,672,431 · 2010PEPTIDE VIRAL ENTRY INHIBITORSUS 7,592,315 · 2009ERK2 CRYSTALSUS 7,312,061 · 2007PROCESS FOR THE PRODUCTION OF DENDRITIC TRIMESIC ACID TRIAMIDESUS 7,199,268 · 2007METHOD FOR PRODUCING AND SCREENING MASS-CODED COMBINATORIAL LIBRARIES FOR DRUG DISCOVERY AND TARGET VALIDATIONUS 7,169,563 · 2007ADENOSINE RECEPTORUS 7,157,244 · 2007